)
Summit Therapeutics (SMMT) investor relations material
Summit Therapeutics Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company mission and strategic vision
Focused on making a significant difference for cancer patients through innovative therapies.
Ivonescimab, a PD-1 VEGF bispecific antibody, is the lead asset, aiming to improve efficacy and safety over existing standards.
Over 40,000 patients have received ivonescimab globally, with 14 phase III trials ongoing.
Four global studies are sponsored directly, with 10 additional trials in China.
Strategic collaborations and a robust pipeline extend beyond lung cancer.
Clinical data and safety profile
Ivonescimab has demonstrated strong tolerability, with recent HARMONi-6 data meeting its primary endpoint in progression-free survival.
Safety profile is consistent across regions and patient populations, including historically challenging squamous NSCLC.
Cooperative binding and shorter half-life contribute to reduced toxicity and improved efficacy.
Over 3,000 patients have been dosed in clinical settings, with a growing safety pool.
Efficacy and trial outcomes
HARMONi-6 showed a 0.60 hazard ratio, indicating a 40% improvement over standard of care in frontline NSCLC.
Median PFS difference of 11.1 vs. 6.8 months in Harmony 6, with positive physician feedback.
Four positive phase III trials have addressed key questions on efficacy and safety across diverse populations.
Consistent efficacy and safety results observed between Eastern and Western patient cohorts.
Next Summit Therapeutics earnings date
Next Summit Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)